spiriva

(MedPage Today) -- The anticholinergic agent tiotropium (Spiriva) outperformed a beta2-agonist in preventing exacerbations of chronic obstructive pulmonary disease (COPD), according to a randomized, double-blinded trial.

Spiriva, a drug for severe lung disease, works at least as well as Advair for asthma patients who don't get relief from inhalers alone, an NIH-sponsored study finds.

LOS ANGELES (AP) -- Researchers say they've found a possible new treatment for adults with hard-to-control asthma.

Their discovery, however, came at a price....

(MedPage Today) -- Adding the long-acting anticholinergic tiotropium (Spiriva) to a low-dose inhaled glucocorticoid resulted in better asthma control than doubling the dose of the glucocorticoid, a double-blind, three-way trial found.

An FDA committee said new data allay concerns about the risk of stroke and cardiovascular events previously associated with tiotropium (Spiriva), drugmaker Boehringer Ingelheim said.